Bayer Aktiengesellschaft BAYRY
Set alert
13.95 USD -0.04 -0.29%
As of Nov 2, 3:59 PM ET
13.89 Day range 14.03
7.48 52-week range 15.23
- YTD
- +28.93%
- 1 year
- +80.00%
- Open
- 13.94
- Prev close
- 13.99
- Mkt cap
- 54.82B
- Vol
- 75.54K
- Avg vol
- 605.31K
- EPS
- -0.51
- P/E
- 0.00
More statistics
- Low
- 13.89
- High
- 14.03
- Earnings
- Nov 3, 2026
3M chart
Events in this range
- Aug 4, 2026Earnings: 0.29; estimate 0.23; surprise 26.09%
Signals (21)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 2026 | 3 days ago |
| SMA: Bullish | Oct 29, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| RSI: Oversold | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| SMA: Bullish | Aug 18, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
Next earnings
Nov 3, 2026
Expected Nov 3, 2026. Consensus EPS estimate 0.13.
Financials — quick view
BAYRY Revenue — annual 28.96B
BAYRY Net income — annual 1.68B
BAYRY EPS — annual 2.22
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2026 | Sep 30, 2026 | 0.13 | — | — | — |
| Aug 4, 2026 | Jun 30, 2026 | 0.23 | 0.29 | +0.06 | +26.09% |
| May 12, 2026 | Mar 31, 2026 | 0.64 | 0.79 | +0.15 | +23.44% |
| Mar 4, 2026 | Dec 31, 2025 | 0.18 | 0.18 | 0.00 | 0.00% |
| Nov 12, 2025 | Sep 30, 2025 | 0.13 | 0.17 | +0.04 | +30.77% |
| Aug 6, 2025 | Jun 30, 2025 | 0.25 | 0.35 | +0.10 | +40.00% |
News
- Bayer Gets in China Its First Global Approval for Stroke Prevention Drug
- Bayer: Turnaround Is Gaining Momentum, But Debt Remains A Risk
- Bayer to Present New Cardiac Amyloidosis and Heart Failure Data at the Heart Failure Society of America (HFSA) Annual Scientific Meeting
- Bayer Seeks Kerendia Label Expansion in Non-Diabetic CKD
- Actress and Menopause Advocate Melissa Joan Hart Partners with Bayer to Raise Awareness about Lynkuet® (elinzanetant), a Prescription Treatment for Moderate to Severe Hot Flashes due to Menopause
- U.S. FDA Accepts Bayer's Supplemental New Drug Application for KERENDIA® (finerenone) to Treat Adults with Chronic Kidney Disease (CKD) Without Diabetes
- BAYRY vs. RHHBY: Which Stock Should Value Investors Buy Now?
- Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion
- Bayer to invest $2.2 billion in new US pharma site
- Bayer to Invest 2.2 Billion U.S. Dollars in a New Manufacturing Site in the United States
Your note
Sign in to keep a note on BAYRY — it syncs with the Stock Master app.